Friday, 19 November 2021

BUSINESS SCHOOL APPLICATION UPTICK REFLECTS STAYING POWER BEYOND 2020 - GMAC CEO

KUALA LUMPUR, Nov 18 (Bernama) -- The Graduate Management Admission Council™ (GMAC), a global association of leading graduate business schools has released its anticipated annual 2021 Application Trends Survey.

The survey of nearly 1,000 MBA and business master’s programmes found that in 2021, the volume of applications for graduate business school programmes grew 0.4 per cent from the year before, sustaining the elevated demand since the onset of a global pandemic in 2020 when business schools worldwide saw unusually high volume of applications due to the economic uncertainty.

“Candidates looked for alternative career options during the COVID induced recession and business schools introduced more flexible admissions policies, resulting in soaring application volumes last year,” said GMAC president and CEO, Sangeet Chowfla in a statement.

“The question was whether this was a fleeting event caused by the pandemic or the start of a new uptick in applications. In this context, the 2021 application cycle indicates that the surging demand for graduate business education is not a passing fad but has staying power beyond 2020.”

Among others, key findings have revealed that after years of unwelcoming immigration policies in parts of the world and months of global travel restrictions due to COVID-19, pent-up demand from international students for graduate business schools was evident in this year’s data.

Weighted absolute year-on-year change in application volumes from international candidates shows an increase of 4.1 per cent compared to a decline of 3.8 per cent from domestic candidates, the applicants who are citizens of the country where a programme is located.

The share of full-time two-year MBA programmes showing growth in applications from international candidates has doubled from 28 per cent in 2019 to 57 per cent in 2021.

Full-time MBA programmes continued gaining traction in 2021. Half of full-time one-year (52 per cent) and two-year (56 per cent) MBA programmes report an increase in applications in 2021, above all programmes averaged at 41 per cent.

 

To learn more, visit www.gmac.com

-- BERNAMA

BANDAI SPIRITS CO LTD OF TOKYO HOLDS 'TAMASHII NATION ONLINE 2021', NOV 19-21

KUALA LUMPUR, Nov 18 (Bernama) -- Under the flagship brand of adult target audience collectibles, ‘TAMASHII NATIONS’, BANDAI SPIRITS CO LTD of Tokyo will be holding the online event ‘TAMASHII NATION ONLINE 2021’ from Nov 19 to 21.

‘TAMASHII NATION’ is an event held once a year since 2008, featuring the latest in figures targeting the adult audience, according to a statement.

This year, the event will be powered by MIRAIKEN studio led by BANDAI NAMCO Entertainment Inc.

MIRAIKEN studio was established in 2021 as a standalone base of operations powered with the latest in equipment available in Japan to create and transmit the next generation in entertainment using technologies such as xR and real-time motion capture.

The event will be featuring approximately 550 hero and robot figures from the ‘MOBILE SUIT GUNDAM’ series, ‘MACROSS’ series, ‘KAMEN RIDER’ series, the ‘TIGER & BUNNY 2’ television anime that will be aired in 2022, and more, with approximately 180 figures new to the line-up.

Online initiatives such as multi-channel streaming programmes, access to a PIP function that enables viewing of videos while looking at the displays, use of a live commerce function to seamlessly purchase featured products, a 360-degree-view figure display function, comment posting function, and more can be enjoyed right at the viewer's fingertips.

The online event will be held in the virtual city, ‘TAMASHII NATION VIRTUAL WORLD’. Within this world are three display areas -- ‘Robot City’, ‘Live Action City’, and ‘Anime & Game City’. These cities will feature a ‘station’ for every featured product and brand where event participants can view a variety of themed products.

The visual concept for ‘TAMASHII NATION VIRTUAL WORLD’ was designed by Yohei Takamatsu who worked as art director for a number of Studio Ghibli titles and also cooperatively handled the art direction for ‘The Boy and the Beast’.

-- BERNAMA

Thursday, 18 November 2021

AM BEST ASSIGNS CREDIT RATINGS TO ETIQA GENERAL INSURANCE BERHAD

SINGAPORE, Nov 17 (Bernama-BUSINESS WIRE) -- AM Best has assigned a Financial Strength Rating of A- (Excellent) and a Long-Term Issuer Credit Rating of “a-” (Excellent) to Etiqa General Insurance Berhad (EGIB) (Malaysia). The outlook assigned to these Credit Ratings (ratings) is stable.

The ratings reflect EGIB’s balance sheet strength, which AM Best assesses as strong, as well as its strong operating performance, neutral business profile and appropriate enterprise risk management (ERM). The ratings also factor in a neutral impact from the company’s ultimate majority ownership by Malayan Banking Berhad (Maybank group), one of the largest financial services groups incorporated, listed and domiciled in Malaysia.

EGIB’s balance sheet strength is underpinned by its risk-adjusted capitalisation, as measured by Best’s Capital Adequacy Ratio (BCAR), which is expected to remain at the strongest level over the medium term. AM Best views the company as having a moderate risk investment strategy with it holding a combination of low-risk assets, including cash, deposits and fixed-income instruments, albeit with notable exposure to higher-risk assets of non-rated fixed-income instruments, equities and real estate. In addition, the company exhibits high reinsurance usage and dependence, with a net retention ratio of 37% in 2020. The company’s reinsurance recoverables are also a large balance sheet item, equivalent to three times its shareholders’ equity at the end of 2020. Furthermore, AM Best views EGIB to be exposed to heightened credit/dispute risk arising from reinsurance recoverables from historical aviation losses.

EGIB’s operating performance is assessed as strong, with a five-year average non-life operating ratio of approximately 69% (2016-2020). Low net loss experience in the company’s core business lines of fire and personal accident, as well as favourable reinsurance commission income from ceded risks, have been the key drivers of technical profitability over recent years, albeit in part offset by underwriting losses from the company’s motor business. Overall earnings have been supported by favourable underwriting performance and consistent investment income. Prospectively, AM Best expects a challenging operating environment arising from the COVID-19 pandemic and the continued phased liberalisation of motor and fire insurance business in Malaysia. Nonetheless, EGIB continues to enhance its pricing and risk selection capabilities, as well as strengthen its distribution and product design, which are expected to support continued strong underwriting and operating performance.

The business profile assessment of neutral reflects EGIB’s position as the sixth largest general insurer in Malaysia with a market share of over 7%, based on 2020 gross direct written premium. The company’s underwriting portfolio is diversified moderately by line of business and distribution channel, albeit with all business originating from Malaysia.

AM Best views EGIB’s ERM approach as appropriate given the current size and complexity of its operations. Risk management capabilities are typically considered appropriate relative to the profile of the company’s key risks, although there are some areas where AM Best views EGIB’s risk management capability as marginal relative to the associated risk profile.

These assigned ratings were the result of an accepted appeal from EGIB.

Ratings are communicated to rated entities prior to publication. Unless stated otherwise, the ratings were not amended subsequent to that communication.

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2021 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED. 

http://mrem.bernama.com/viewsm.php?idm=41609

Celltrion secures CHMP positive opinion for regdanvimab (CT-P59) over COVID-19 treatment

KUALA LUMPUR, Nov 15 -- Celltrion Group has announced the European Medicine’s Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive scientific opinion recommending marketing authorisation for regdanvimab (CT-P59).

regdanvimab (CT-P59) is a monoclonal antibody treatment for adults with COVID-19 that do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19.

The CHMP positive opinion is a scientific recommendation to the European Commission (EC), which authorises marketing approval in the European Union, according to a statement.

“We have accumulated the safety and efficacy data of regdanvimab in the treatment of patients infected with COVID-19 and its associated variant strains, including the more virulent Delta variant,” said Head of Medical and Marketing Division at Celltrion Healthcare, Dr HoUng Kim, Ph.D.

“At Celltrion, we are proud to play our part in tackling the unprecedented global threat of COVID-19 and believe regdanvimab offers an important addition to the treatment arsenal.”

The positive CHMP opinion was supported by data from the global Phase III clinical trial in which Celltrion enrolled more than 1,315 people to evaluate the efficacy and safety of regdanvimab in 13 countries including the US, Spain, and Romania.

Data showed regdanvimab significantly reduced the risk of COVID-19 related hospitalisation or death by 72 per cent for patients at high-risk of progressing to severe COVID-19.

Rolling review of regdanvimab had been initiated by the EMA in February this year and the announcement of the CHMP positive opinion for regdanvimab follows the submission of a marketing authorisation application (MAA) to the EMA seeking approval of regdanvimab in October.

More details at https://www.celltrionhealthcare.com/en-us.

-- BERNAMA

ONWARD: NOVEL BLOOD PRESSURE STABILISATION THERAPY PRESENTED AT NEUROSCIENCE 2021

KUALA LUMPUR, Nov 17 (Bernama) -- Medical technology company, ONWARD Medical N.V. announced GrĂ©goire Courtine, Ph.D. has demonstrated the effectiveness of ONWARD’s ARC Therapy to stabilise blood pressure after spinal cord injury during his Presidential Special Lecture at NEUROSCIENCE 2021.

Courtine is Professor of Neuroscience at the Swiss Federal Institute of Technology (EPFL) and co-Director of NeuroRestore, according to a statement.

“Paralysis and loss of sensation are the more commonly known impacts of spinal cord injury, but a potentially more serious complication is orthostatic hypotension - low blood pressure tied to changes in body position.

“We were excited to demonstrate and discuss how this new approach may provide a viable and important therapy for people with spinal cord injury,” he said.

This novel therapy is currently being investigated in the STIMO HEMO study, building on a discovery first published in Nature that identifies the low thoracic spinal cord as a hemodynamic ‘hotspot’, which when stimulated via a proprietary algorithm called ARC Therapy, has the potential to restore blood pressure stability after spinal cord injury.

During his Presidential Special Lecture, Courtine showed how stimulation of the hemodynamic hotspot elevated blood pressure in one of the STIMO HEMO participants. 

ONWARD Medical N.V. creates innovative therapies to restore movement, independence, and health in people with spinal cord injury.

ONWARD’s work builds on over a decade of basic science and preclinical research conducted at the world’s leading neuroscience laboratories.

It is headquartered at the High Tech Campus in Eindhoven, the Netherlands and the EPFL Innovation Park in Lausanne, Switzerland, with a growing US presence in Boston, Massachusetts, USA.

-- BERNAMA

DREAMING BACK TO THE DESERT -- THE POSTCARD THAT NEVER FADES IN NINGXIA

 

Shapotou, is not to be missed once you visit Ningxia. (Image source: Department of Culture and Tourism Ningxia, China)

KUALA LUMPUR, Nov 16 (Bernama) -- The majestic desert scenery, the beautiful scenery in the hinterland, the ancient civilization of the Yellow River, and the towering Helan mountains, and all such rich tourism resources make Ningxia an indispensable stop for tourists on the northwest line in China, especially the world famous desert of Ningxia.
 
“The smoke above the chimneys go straight up against the solitary desert, the setting sun looms larger and rosier”, the poem impressed us deeply by describing  Ningxia as " The Oasis in the Hinterland", and what’s more , among all the desert scenic spots in Ningxia, Shapotou scenic spot in Zhongwei is top-ranking.  
 
It’s really enjoyable  to go camping at night under the starry sky on desert of Shapotou, cheer with two or three friends, Share the food  and the stories with your friends . Maybe this is the life you yearn for. The bonfire will let you relax and enjoy the vacation. The poem and the distance are right in front of you.
 
In Shapotou, you can enjoy the sunrise of the desert, the sunset of the Yellow River, and the most beautiful starry sky. Immersed in here, you can hear the faintly beautiful camel bells, telling the story of the ancient and tranquil frontier fortress. The Yellow River is running and the sands of desert are endless. Here, there are not only ancient sheepskin rafts, but also modern exciting Yellow River rope, and not only sand skaters full of modern speed, but also camel teams with great historical color. In Shapotou, time seems to be static, with only constant scenery. It silently records the tourists who have come and gone for thousands of years, like an indelible postcard, recording the stories that only belong to Ningxia.

SOURCE: Department of Culture and Tourism Ningxia, China
 
FOR MORE INFORMATION, PLEASE CONTACT: 
Email: info@gtcgroup.my

--BERNAMA

Wednesday, 17 November 2021

NANOTRONICS REVEALS NEW NSPEC® MACRO STANDALONE SYSTEM




KUALA LUMPUR, Nov 16 (Bernama) -- Nanotronics, developer of nSpec®, the world’s most advanced robotic microscope for industrial inspection, has unveiled nSpec Macro Standalone at SEMICON Europa, the largest European electronics platform connecting industry leaders across the entire design and manufacturing supply chain.

This latest addition within the nSpec® portfolio enables automatic capture and analysis of images to detect and quantify defects and features of interest.

According to a statement, the small footprint of the device allows for operators to have a desktop tool that can immediately produce high resolution images, successfully identifying and defining causality to these features of interest.

“The addition of this system to our product portfolio enables earlier detection of device killing defects to further reduce customer costs and waste,” said Matthew Putman, PhD, CEO and co-founder of Nanotronics.

“Providing manufacturers with the ability to significantly increase production yields, particularly during a time when strict quality standards should be of the utmost importance, seems like the most effective and efficient way to help mitigate the supply chain crisis.”

The nSpec Macro system is designed for inspection of bare or patterned wafers up to 200mm. The system provides full sample illumination and the ability to individually modify the LEDs to adjust intensity, colour, and location of illumination for complete flexibility. The minimum defect resolution ranges from 50 to 100 microns, contingent on field of view or wafer sizes.

Nanotronics will provide onsite demonstrations at SemiCon Europa from Nov 16 – 19.

To learn more visit https://nanotronics.co.

-- BERNAMA